{"id":1824293,"name":"Vallon Pharmaceuticals Inc","transferAgent":{"dtcMemberId":7824,"name":" BROADRIDGE CORPORATE ISSUER SOLUTIONS INC./DRS                        "},"allClaimedTransferAgents":[{"dtcMemberId":7824,"name":" BROADRIDGE CORPORATE ISSUER SOLUTIONS INC./DRS                        ","asOfDate":{"value":"2022-06-06"},"docUrl":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000046/definitiveproxyspecialshme.htm"},{"dtcMemberId":7824,"name":" BROADRIDGE CORPORATE ISSUER SOLUTIONS INC./DRS                        ","asOfDate":{"value":"2022-04-27"},"docUrl":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000027/a2022proxystatement.htm"}],"tickers":[{"ticker":"VLON","exchange":"Nasdaq","description":null,"hasOnlinePurchase":null,"cusip":"92023M101"}],"holders":{"filingDate":{"value":"2022-02-14"},"totalHolders":7,"docUrls":["1824293/000182429322000004/ck0001824293-20211231.htm"]}}